<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00888303</url>
  </required_header>
  <id_info>
    <org_study_id>MD123</org_study_id>
    <nct_id>NCT00888303</nct_id>
  </id_info>
  <brief_title>Single Dose Steroid Before Thyroidectomy for Benign Disease to Improve Postoperative Nausea, Pain, and Vocal Function</brief_title>
  <official_title>Randomized Controlled Trial on Efficacy of Preemptive 8 mg of Dexamethasone for Reducing Pain and Postoperative Nausea and Vomit After Thyroidectomy for Benign Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Misericordia e Dolce</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Misericordia e Dolce</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of 8 mg of dexamethasone administered
      prior surgery, to reduce pain, postoperative nausea and vomiting and to improve vocal
      function after thyroidectomy for benign disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative nausea and vomit (PONV) measured in 4 grades</measure>
    <time_frame>8, 24, 32 and 48 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain after thyroidectomy measured in a 0-100 Visual analog scale</measure>
    <time_frame>8, 24, 32 and 48 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vocal function measured in a 0-100 Visual analog scale</measure>
    <time_frame>8, 24, 32 and 48 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea and Vomit</condition>
  <condition>Postoperative Vocal Function</condition>
  <condition>Thyroidectomy</condition>
  <arm_group>
    <arm_group_label>A (dexamethasone)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 minutes before total or partial thyroidectomy for benign disease a single dose of intravenous 8 mg/2mL of dexamethasone is administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B (Control)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 minutes before total or partial thyroidectomy for benign disease 100 mg of saline solutions are administered intravenous</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>20 minutes before total or partial thyroidectomy for benign disease a single dose of intravenous 8 mg/2mL of dexamethasone is administered</description>
    <arm_group_label>A (dexamethasone)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline solution</intervention_name>
    <description>20 minutes before total or partial thyroidectomy for benign disease 100 mg of saline solutions are administered intravenous</description>
    <arm_group_label>B (Control)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thyroidectomy, total or partial</intervention_name>
    <description>Surgical standard intervention</description>
    <arm_group_label>A (dexamethasone)</arm_group_label>
    <arm_group_label>B (Control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Patients undergoing thyroidectomy

        Exclusion Criteria:

          -  Patients who had received antiemetic therapy within 48 hours before surgery

          -  Patients with depression

          -  Chronic pain disorder

          -  Insulin-dependent diabetes mellitus

          -  History of severe and/or repeated PONV after previous minor surgery, that led to
             change from standard anesthetic protocol

          -  Pregnancy

          -  Age &lt; 18 years

          -  Patients who had known malignant disease or had undergone previous thyroid or neck
             surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Scatizzi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Misericordia and Dolce Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Rettori, MD</last_name>
    <role>Study Director</role>
    <affiliation>Misericordia and Dolce Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Feroci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Misericordia and Dolce Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Feroci, MD</last_name>
    <phone>+393398382381</phone>
    <email>fferoci@yahoo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marco Scatizzi, MD</last_name>
    <phone>+39574434647</phone>
    <email>marco.scatizzi@usl4.toscana.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Misericordia and Dolce Hodpital</name>
      <address>
        <city>Prato</city>
        <state>Po</state>
        <zip>59100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Feroci, MD</last_name>
      <phone>+393389592375</phone>
      <email>fferoci@yahoo.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Feroci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Borrelli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Worni M, Schudel HH, Seifert E, Inglin R, Hagemann M, Vorburger SA, Candinas D. Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function. Ann Surg. 2008 Dec;248(6):1060-6. doi: 10.1097/SLA.0b013e31818c709a.</citation>
    <PMID>19092351</PMID>
  </results_reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2009</study_first_submitted>
  <study_first_submitted_qc>April 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2009</study_first_posted>
  <last_update_submitted>September 1, 2012</last_update_submitted>
  <last_update_submitted_qc>September 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Misericordia e Dolce</investigator_affiliation>
    <investigator_full_name>Marco Scatizzi</investigator_full_name>
    <investigator_title>Md</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

